The notices it replaced
- Reissues: PAR-11-219 NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
Replaced by PAR-15-165.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,822,705 in first-year total cost, median $963,561.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]1
- Special Emphasis Panel[ZAR1 KM (M2)]1
- Special Emphasis Panel[ZAR1 XZ (M2)]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- CINCINNATI CHILDRENS HOSP MED CTR1
- WAKE FOREST UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Real-Time Sensorimotor Feedback for Injury Prevention Assessed in Virtual Reality1U01AR067997-01A1 | MYER, GREGORY DONALD | CINCINNATI CHILDRENS HOSP MED CTR, OH | $698,292 | AMSC |
| 2015 | Weight Loss and Exercise for Communities with Arthritis in North Carolina (WE-CAN)1U01AR068658-01 | JORDAN, JOANNE M.MESSIER, STEPHEN P | WAKE FOREST UNIVERSITY, NC | $1,160,852 | ZAR1 |
| 2015 | Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL1U01AR068043-01A1 | BATHON, JOAN MARIESOLOMON, DANIEL HAL | BRIGHAM AND WOMEN'S HOSPITAL, MA | $963,561 | ZAR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.